Skip to main content
XLO logo

XLO · Xilio Therapeutics, Inc. · Holdings

Track XLO — free
$8.93 +0.00 (+0.00%) At close · Sep 11
Market Cap
$51.64M
Shares
5.78M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 26
Total Value: $32,638,867
Total Shares: 3,406,981

Institutional Ownership Trend

19 quarters

Holder Concentration

Across 26 13F filers · Δ vs Mar 31, 2026
Top Holder
19.5%
Sep 2023 → Jun 2026 · range 17.1% – 41.3%
−5.9 pts
Top 5
75.0%
Sep 2023 → Jun 2026 · range 65.3% – 81.1%
−1.8 pts
Top 10
93.0%
Sep 2023 → Jun 2026 · range 89.6% – 95.8%
+1.3 pts
HHI
1,322
Sep 2023 → Jun 2026 · range 1,108 – 2,298
Broadly held−312

Quarterly Activity

vs Mar 31, 2026
New
10
Increased
4
Decreased
4
Sold Out
8
Unchanged
8
Holder count: +2
Institutional value: +48.2%
Shares held: +30.1%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 26 of 26
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1840233 CUSIP 98422T209 13F (30d) 13 filings 13 filers Visit website Investor relations